Education
About Us
Working with TipRanks
Follow Us
Zentek (ZTEK)
NASDAQ:ZTEK
ZTEK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.50 - $1.84
Previous CloseN/A
Volume66.53K
Average Volume (3M)43.30K
Market Cap
$74.93M
Enterprise Value$152.72M
Total Cash (Recent Filing)$121.48K
Total Debt (Recent Filing)$680.47K
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding104,710,460
10 Day Avg. Volume36,639
30 Day Avg. Volume43,298
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.04
Enterprise Value/Revenue175.04
Enterprise Value/Gross Profit-99.48
Enterprise Value/Ebitda-16.34
Forecast
1Y Price Target
$1.08Price Target Upside58.82% Upside
Rating ConsensusHold
Number of Analyst Covering0
Zentek News
ZTEK FAQ
What was Zentek’s price range in the past 12 months?
Zentek lowest stock price was $0.50 and its highest was $1.84 in the past 12 months.
What is Zentek’s market cap?
Zentek’s market cap is $74.93M.
When is Zentek’s upcoming earnings report date?
Zentek’s upcoming earnings report date is Nov 17, 2025 which is in 85 days.
How were Zentek’s earnings last quarter?
Zentek released its earnings results on Aug 14, 2025. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.
Is Zentek overvalued?
According to Wall Street analysts Zentek’s price is currently Undervalued.
Does Zentek pay dividends?
Zentek does not currently pay dividends.
What is Zentek’s EPS estimate?
Zentek’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zentek have?
Zentek has 104,710,460 shares outstanding.
What happened to Zentek’s price movement after its last earnings report?
Zentek reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.173%.
Which hedge fund is a major shareholder of Zentek?
Currently, no hedge funds are holding shares in ZTEK
Zentek Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.08 (58.82% Upside)
$1.08 (58.82% Upside)
Hedge Fund Trend
Decreased
By 3.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.29%
12-Months-Change
Fundamentals
Return on Equity
-53.76%
Trailing 12-Months
Asset Growth
-11.29%
Trailing 12-Months
Company Description
Zentek
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Technical Analysis
Arch Biopartners
―
Medicenna Therapeutics Corp
―
Quipt Home Medical
―
High Tide
―
Eupraxia Pharmaceuticals
―
Ownership Overview
Options Prices
Currently, No data available
---